| Agreement with Olympus Expands Open Track Automation Solution for Clinical Laboratories |
| |
| |
November 11 2008 |
| |
| |
|
| |
CENTER VALLEY, Pa. November 11, 2008 – Olympus America Inc. has signed an agreement with Thermo Fisher Scientific to enhance Olympus' laboratory automation offerings to U.S. customers with a comprehensive open track automation solution for clinical laboratories. The new product offering will complement existing Olympus Lab Automation products including the OLA2500®. The agreement between the companies will allow laboratory professionals to create best-of-breed comprehensive solutions incorporating Olympus AU®-series clinical chemistry and immunoassay analyzers including various third-party analyzers. The open track-based system will offer mid-sized to large hospital and regional laboratories unprecedented flexibility and access to additional test capabilities, and it will also allow customers to consolidate and automate such sample processing procedures as decapping, centrifugation, aliquoting, recapping and storage/retrieval, which is in development. The agreement enables Olympus to distribute the Thermo Scientific TCAutomation™ product line, a fully featured, track-based laboratory automation product line, in the Americas. Olympus will handle sales and marketing and provide primary level service and support of the automation products.
“We are delighted to have the opportunity to further expand our presence in the United States with new chemistry options and applicability in broader areas of the lab. Olympus’ strength in high-throughput clinical chemistry is a key advantage for customers who are designing a comprehensive system that includes our products,” said Bill Ostman, vice president and general manager of Thermo Fisher’s Clinical Diagnostics Finland unit.
“The use of the Thermo Scientific open track with our Olympus clinical chemistry systems will allow our customers to build cost-effective, consolidated systems. Customers can achieve automation and integration without compromise, allowing them to better meet the pressures of reduced staffing and increased efficiency demands,” added Hiro Sekiya, director of marketing for the Olympus America Inc., Diagnostic Systems Group.
Key benefits of laboratory automation include more efficient sample management, improved laboratory services and shortened turnaround times. By automating the main pre-analytical steps, such as centrifugation, decapping, aliquoting and sorting, Thermo Scientific TCAutomation products help to manage current and future workloads; it interfaces with Olympus chemistry systems plus a wide selection of third-party instruments.
About Olympus Diagnostic Systems
Olympus Diagnostic Systems provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks, physician offices and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, maximize productivity, and deliver fast, reliable results.
About Olympus
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products. Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
- Gastrointestinal endoscopes, accessories, and minimally invasive surgical products
- Advanced clinical and research microscopes
- Lab automation systems, chemistry-immuno and blood bank analyzers and reagents
- Digital cameras and voice recorders
Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
|
|
|
|
0 Items